Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-138123

Xenbase Image ID: 138123


Figure 3 cnrip1 knockdown reduces expression of sox2, otx2, pax6 and rax. (A) qRT-PCR analysis for the pan-neural marker sox2 (stage 10.5 and 12.5), the anterior marker otx2 (stage 10.5 and 12.5), the eye and neural marker pax6 (stage 12.5 and 24) and the eye marker rax (stage 12.5 and 24) in embryos injected with control MO or cnrip1 MO (10 ng each/blastomere) into the animal region of two dorsal blastomeres at the 4-cell stage. The expression level of each gene was normalized to that of odc. Values are mean SD of three independent experiments; **P < 0.01; *P < 0.05. (B) Whole-mount in situ hybridization was carried out on MO-injected embryos. Control MO or cnrip1 MO (10 ng each) was injected into the animal region of the left dorsal blastomere at the 4-cell stage. The expression of sox2, otx2, pax6 and rax was reduced in 100% of cnrip1 MO-injected embryos (sox2, stage 10.5, n = 20; sox2, stage 12.5, n = 24; otx2, stage 10.5, n = 20; otx2, stage 12.5, n = 24; pax6, stage 12.5, n = 30; pax6, stage 24, n = 24; rax, stage 12.5, n = 24; rax, stage 24, n = 24). Anterior views with dorsal upwards. The representative results from two (sox2, stage 10.5; otx2, stage 10.5) or three (sox2, stage 12.5; otx2 stage 12.5; pax6, stage 12.5 and 24; rax, stage 12.5 and 24) independent experiments are shown. The black brackets indicate MO-injected left sides. The dashed lines indicate midlines of embryos.

Image published in: Zheng X et al. (2015)

Copyright © 2015. Image reproduced with permission of the Publisher, John Wiley & Sons.

GeneSynonymsSpeciesStage(s)Tissue
sox2.Lanop3, LOC108718087, mcops3, Sox-2, XLSOX-2, Xsox-2, XSox2X. laevisThroughout NF stage 10.5anterior
dorsal
otx2.Sotx-2, otx2-a, otx2-b, otxA, Xotx-2, Xotx2X. laevisThroughout NF stage 10.5anterior
dorsal
pax6.Lan2, mgda, pax-6, pax6-a, pax6-b, wagr, XLPAX6, xpax6X. laevisThroughout NF stage 12.5neural plate
anterior placodal area
dorsal
optic field
rax.Srax-a, rax-b, rax1, rx, rx-1, rx1, rx1a, Rx2A, Xrax, Xrx1, Xrx1AX. laevisThroughout NF stage 12.5anterior
anterior placodal area
optic field

Image source: Published

Experiment + Assay Source Phenotypes and Disease
Xla Wt + cnrip1 MO + NF10.5 (in situ hybridization) fig.3.b
Expression Phenotype
decreased amount otx2.S expression in marginal zone
decreased amount sox2.L expression in marginal zone
Xla Wt + cnrip1 MO + NF12.5 (in situ hybridization) fig.3.b
Expression Phenotype
decreased amount otx2.S expression in pre-chordal neural plate
decreased amount pax6.L expression in anterior placodal area
decreased amount pax6.L expression in neural plate
decreased amount pax6.L expression in optic field
decreased amount rax.L expression in anterior placodal area
decreased amount rax.L expression in optic field
decreased amount sox2.L expression in neural plate
Xla Wt + cnrip1 MO + NF24 (in situ hybridization) fig.3.b
Expression Phenotype
decreased amount pax6.L expression in brain
decreased amount pax6.L expression in eye
decreased amount rax.L expression in eye

Larger Image
Printer Friendly View

Return to previous page